0026-895X/03/6402-447-455$20.00
Mol Pharmacol 64:447-455, 2003
Requirement of G
and c-Src in D2 Dopamine Receptor-Mediated Nuclear Factor-
B Activation
Ming Yang1,
Hongmei Zhang1,
Tatyana Voyno-Yasenetskaya, and
Richard D. Ye
Department of Pharmacology, College of Medicine, University of Illinois,
Chicago, Illinois
The D2 dopamine receptor (D2R) was examined for its ability to mediate
nuclear factor-
B (NF-
B) activation through G proteins.
Stimulation of D2R-transfected HeLa cells with its agonist quinpirole induced
the expression of a NF-
B luciferase reporter and formation of
NF-
B-DNA complex. This response was blocked by pertussis toxin, and by
the G
scavengers transducin and
-adrenergic receptor kinase
1 carboxyl-terminal fragment. Unlike Gi-coupled chemoattractant
receptors, D2R activated NF-
B without an increase in phospholipase
C-
activity, and the response was only slightly affected by the
phosphoinositide 3-kinase inhibitor
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). In
contrast, treatment with genistein and
4-amino-1-tert-butyl-3-(p-methylphenyl)pyrazolo[3,4-d]
pyrimidine abolished the induced NF-
B activation, suggesting
involvement of protein tyrosine kinases. Activation of D2R led to
phosphorylation of c-Src at Tyr-418, and expression of a kinase-deficient
c-Src inhibited D2R-mediated NF-
B activation. The D2R-mediated
NF-
B activation was not dependent on epidermal growth factor (EGF)
receptor transactivation since
4-(3'-chloroanilino)-6,7-dimethoxyquinazoline (AG1478), an EGF
receptor-selective tyrphostin used at 1 µM, blocked EGF-induced NF-
B
activation but not the quinpirole-induced response. In addition, the
D2R-mediated NF-
B activation was enhanced by over-expression of
-arrestin 1. These results suggest that D2R-mediated NF-
B
activation requires G
and c-Src, and possibly involves
-arrestin 1.
Received April 10, 2003;
accepted May 9, 2003
Address correspondence to: Richard D. Ye, Department of Pharmacology,
M/C 868, University of Illinois at Chicago, 835 S. Wolcott Avenue, Chicago, IL
60612. E-mail:
yer{at}uic.edu
This article has been cited by other articles:

|
 |

|
 |
 
W. Zhang, J.-M. Navenot, N. M. Frilot, N. Fujii, and S. C. Peiper
Association of Nucleophosmin Negatively Regulates CXCR4-Mediated G Protein Activation and Chemotaxis
Mol. Pharmacol.,
November 1, 2007;
72(5):
1310 - 1321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bontempi, C. Fiorentini, C. Busi, N. Guerra, P. Spano, and C. Missale
Identification and Characterization of Two Nuclear Factor-{kappa}B Sites in the Regulatory Region of the Dopamine D2 Receptor
Endocrinology,
May 1, 2007;
148(5):
2563 - 2570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Lin, H.-W. Cheng, M.-J. Hsu, M.-C. Chen, C.-C. Lin, and B.-C. Chen
c-Src Mediates Thrombin-Induced NF-{kappa}B Activation and IL-8/CXCL8 Expression in Lung Epithelial Cells.
J. Immunol.,
September 1, 2006;
177(5):
3427 - 3438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. F. Liu and Y. H. Wong
Activation of Nuclear Factor {kappa}B by Somatostatin Type 2 Receptor in Pancreatic Acinar AR42J Cells Involves G{alpha}14 and Multiple Signaling Components: A MECHANISM REQUIRING PROTEIN KINASE C, CALMODULIN-DEPENDENT KINASE II, ERK, AND c-Src
J. Biol. Chem.,
October 14, 2005;
280(41):
34617 - 34625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. F. Liu and Y. H. Wong
G16-mediated Activation of Nuclear Factor {kappa}B by the Adenosine A1 Receptor Involves c-Src, Protein Kinase C, and ERK Signaling
J. Biol. Chem.,
December 17, 2004;
279(51):
53196 - 53204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Bakker, P. Casarosa, H. Timmerman, M. J. Smit, and R. Leurs
Constitutively active Gq/11-coupled Receptors Enable Signaling by Co-expressed Gi/o-coupled Receptors
J. Biol. Chem.,
February 13, 2004;
279(7):
5152 - 5161.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics